Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Moderate renal impairment (eGFR 15-60) typically permits use with monitoring
By engaging the GLP-1 receptor, and for tirzepatide-based compounds the GIP receptor as well, it slows gastric emptying, dampens post-meal glucose spikes, and amplifies satiety signaling in the hypothalamus
Instead of forcing the system, it works with your bodys natural rhythms
| How long does it take to see results
US$ 23.25
US$ 28.26
US$ 26.11
US$ 24.64
